AGM/EGMApr 28, 2026, 04:48 PM
GANX Schedules 2026 Annual Meeting; Elects Directors, Ratifies Auditor
AI Summary
Gain Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held on Wednesday, June 24, 2026, at 8:30 a.m. Eastern time. Stockholders will vote on the election of seven director nominees and the ratification of Ernst & Young AG as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date for stockholders entitled to vote is April 27, 2026, with 42,654,038 shares outstanding.
Key Highlights
- 2026 Annual Meeting of Stockholders scheduled for June 24, 2026, at 8:30 a.m. Eastern time.
- Stockholders to elect seven nominees for director until the 2027 Annual Meeting.
- Stockholders to ratify Ernst & Young AG as independent auditor for fiscal year ending December 31, 2026.
- Record date for voting is April 27, 2026.
- 42,654,038 shares of common stock outstanding and entitled to vote as of the record date.
Price Impact
More from GANX